s6y
Company name or ticker
Search
BridgeBio Oncology Therapeutics, Inc.
4
Ben Yong: Statement of changes in beneficial ownership of securities
Filed
Monday, October 5, 2026
Period
Oct 1, 2026
Accession number
0001193125-26-414123
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header